Phaseline

Companies › Viking Therapeutics

Viking Therapeutics: clinical trials, targets and expected readouts

2 active drug programs in 4 registered trials: 2 Phase 3, 2 Phase 1; Metabolic and endocrine; next expected readout Nov 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
VK2735
GLP-1 and GIP dual agonist
GLP1R, GIPRPhase 3Weight Loss; Obese AdultsMay 2027
VK3019
GLP-1 receptor agonist
–Phase 1Obese AdultsNov 2026

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07846033VK3019Phase 1Obese AdultsMetabolic and endocrineNov 2026
NCT07838740VK2735Phase 1Obese AdultsMetabolic and endocrineMay 2027
NCT07104500VK2735Phase 3Weight LossMetabolic and endocrineJul 2027
NCT07104383VK2735Phase 3Weight LossMetabolic and endocrineJul 2027

From the company's SEC filings

Cash and short-term investments of $960m on 2026-09-30; operating cash outflow about $506m a year; runway about 23 months at that burn, to Aug 2028; 2 of 2 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Agreements filed with the SEC (item 1.01), last two years

Specialist investors

Held by 5 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.

Targets

GLP1R (1) GIPR (1)

Companies with the same targets

Eli Lilly Novo Nordisk Roche Hangzhou Sciwind Biosciences Amgen Regeneron Pharmaceuticals Pfizer Hangzhou Zhongmei Huadong Pharmaceutical Hanmi Pharmaceutical Company Hudson Biotech

Companies built like this

Beijing QL Biopharmaceutical Chendu DIAO Pharmaceutical Group Amylyx Pharmaceuticals Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics Medicure

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.